Urica Therapeutics, a Fortress Biotech subsidiary company focused on the development and commercialization of pharmaceutical products to treat gout and chronic 3 October 2022
Belgium’s NeuVasQ Biotechnologies, a Université Libre de Bruxelles (ULB) spin-off developing pharmaceuticals to restore blood-brain barrier function, has named 20 September 2022
ViroCell Biologics, an innovation-driven Contract Development and Manufacturing Organization (CDMO), has announced the appointment of Susan Nichols to its senio 20 September 2022
Privately-held US CAR-T company ImmPACT Bio has tasked Jonathan Benjamin with leading its clinical development strategy as the company’s chief medical officer. 14 September 2022
Storm Therapeutics, a biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other 7 September 2022
Nodus Oncology, a novel biotech company focused on developing first and best-in-class molecules inhibiting novel DNA damage response (DDR) targets, has launched 6 September 2022
Ocugen (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, has announced 1 September 2022
Scandion Oncology, a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, has announced 31 August 2022
Celsius Therapeutics, a biotechnology company developing precision medicines for patients with cancer and autoimmune disease by utilising single-cell RNA sequen 26 August 2022
British biotech Mereo BioPharma has revealed its largest shareholder is agitating to purge certain board members as part of a plan to change the firm’s strategi 23 August 2022
PsiOxus, a clinical-stage biotechnology company developing a novel platform technology for the targeted delivery of therapeutic transgenes to solid tumors, has 12 August 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.